January 31, 2013
3D printing makes its way into cancer research lab
Bioprinting company Organovo today announced a collaboration with Oregon Health & Science University’s Knight Cancer Institute in which it will create 3D models of breast and pancreatic tumors for researchers to use in drug discovery and development. MedCity News reports via @Info3Dprinter.
... Today, researchers use animal models and cell lines to identify and test potential new drugs. Having more robust, 3D disease models for what Carroll called “preclinical-plus” testing could give researchers better insight into how tumors behave and how they respond to drugs.
The Permanent Link to this page is: http://textually.org/3DPrinting/2013/01/031648.htm